Insufficient scRNA-seq data for expression of CLK2 at single-cell level.
Insufficient scRNA-seq data for expression of CLK2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4060.84 | 1445 / 1445 | 100% | 40.02 | 183 / 183 |
ovary | 100% | 6257.41 | 180 / 180 | 100% | 61.78 | 430 / 430 |
prostate | 100% | 6534.88 | 245 / 245 | 100% | 36.86 | 502 / 502 |
stomach | 100% | 3756.89 | 359 / 359 | 100% | 32.43 | 286 / 286 |
lung | 100% | 4329.59 | 578 / 578 | 100% | 45.73 | 1154 / 1155 |
intestine | 100% | 4782.97 | 966 / 966 | 100% | 32.91 | 526 / 527 |
skin | 100% | 4017.69 | 1809 / 1809 | 100% | 46.14 | 471 / 472 |
uterus | 100% | 6223.27 | 170 / 170 | 100% | 58.34 | 458 / 459 |
bladder | 100% | 4638.57 | 21 / 21 | 100% | 48.00 | 502 / 504 |
breast | 100% | 4785.71 | 459 / 459 | 100% | 49.42 | 1113 / 1118 |
thymus | 100% | 7964.90 | 653 / 653 | 100% | 44.10 | 602 / 605 |
pancreas | 100% | 3262.73 | 327 / 328 | 99% | 42.71 | 176 / 178 |
adrenal gland | 100% | 6335.27 | 258 / 258 | 98% | 29.83 | 226 / 230 |
liver | 100% | 3252.94 | 226 / 226 | 97% | 28.91 | 393 / 406 |
brain | 95% | 2253.88 | 2500 / 2642 | 100% | 37.29 | 705 / 705 |
kidney | 100% | 5024.96 | 89 / 89 | 94% | 31.12 | 850 / 901 |
adipose | 100% | 4052.86 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 50.98 | 29 / 29 |
spleen | 100% | 8959.39 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 37.42 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 42.37 | 1 / 1 |
blood vessel | 100% | 3295.06 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 2005.95 | 854 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 31.68 | 79 / 80 |
peripheral blood | 96% | 2874.79 | 893 / 929 | 0% | 0 | 0 / 0 |
muscle | 95% | 1455.64 | 760 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043484 | Biological process | regulation of RNA splicing |
GO_0018108 | Biological process | peptidyl-tyrosine phosphorylation |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0045721 | Biological process | negative regulation of gluconeogenesis |
GO_0010212 | Biological process | response to ionizing radiation |
GO_0016607 | Cellular component | nuclear speck |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0004712 | Molecular function | protein serine/threonine/tyrosine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | CLK2 |
Protein name | Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2) dual-specificity kinase (EC 2.7.12.1) |
Synonyms | hCG_15308 |
Description | FUNCTION: Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Phosphorylates PAGE4 at several serine and threonine residues and this phosphorylation attenuates the ability of PAGE4 to potentiate the transcriptional activator activity of JUN . . |
Accessions | ENST00000368361.9 [P49760-1] ENST00000572269.5 [P49760-3] Q9BRG8 ENST00000355560.4 ENST00000576584.1 B7Z8N6 P49760 B1AVT0 A8K7I0 ENST00000361168.9 [P49760-3] ENST00000574445.5 [P49760-1] |